Related Experiment Video

Updated: Jun 22, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

728

Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas

Kawaljit Kaur1, Jashan Sanghu2,3, Sanaz Memarzadeh2,3,4,5,6

  • 1Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, University of California School of Dentistry, 10833 Le Conte Ave, Los Angeles, CA 90095, USA.

Vaccines
|June 27, 2024
PubMed

Insights

Super-charged NK (sNK) cells show enhanced ability to kill both stem-like and differentiated ovarian cancer cells. Combining sNK cells with chemotherapy offers a promising strategy for treating heterogeneous ovarian tumors.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • High-grade serous ovarian cancers (HGSOCs) comprise poorly differentiated stem-like cells (PDSLCs) and differentiated tumor cells.
  • Conventional therapies fail to eradicate PDSLCs, leading to disease recurrence.
  • Primary natural killer (NK) cells effectively target PDSLCs but have limited efficacy against well-differentiated tumors.

Purpose of the Study:

  • To introduce and characterize super-charged NK (sNK) cells.
  • To evaluate the potential of sNK cells in overcoming therapeutic resistance in HGSOCs.
  • To propose combination strategies involving sNK cells and chemotherapy for ovarian cancer treatment.

Main Methods:

  • Review and discussion of the characteristics of sNK cells.
  • Comparative analysis of cytotoxic potential between primary NK cells and sNK cells.
  • Assessment of cytokine secretion profiles of sNK cells, focusing on tumor differentiation-inducing cytokines.

Main Results:

  • sNK cells demonstrate significantly enhanced direct killing of both PDSLCs and well-differentiated ovarian tumor cells compared to primary NK cells.
  • sNK cells secrete higher levels of cytokines that promote tumor cell differentiation.
  • sNK cells exhibit potential for inducing differentiation in PDSLCs.

Conclusions:

  • sNK cells represent a potent therapeutic candidate for ovarian cancer due to their broad cytotoxic activity.
  • The ability of sNK cells to induce tumor differentiation complements their direct killing capacity.
  • A combination therapy of sNK cells and chemotherapy is proposed as a highly effective strategy to eliminate heterogeneous ovarian tumors.
Keywords:
IFN-γcytokinescytotoxicityhigh-grade serous ovarian cancersimmunotherapiesnatural killer cellsovarian cancersuper-charged NK cells

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.0K
Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

5.6K

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
888
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K